Healthcare Global Enterprises Ltd. Share Price Live Today
NiveshIQ
NSE: HCG · Healthcare
Healthcare Global Enterprises Ltd.
₹586.80▲ ₹1.25 (+0.21%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on HCG. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Healthcare Global Enterprises Ltd.
HealthCare Global Enterprises Limited (HCG) operates across a broad spectrum of oncology and diagnostic services, including cancer diagnostics, molecular imaging, and robotic surgery, positioning it as a comprehensive oncology care provider in India and abroad. The company’s revenue of ₹2,627 crore in FY27 was driven primarily by its diagnostic arm, which accounted for 45% of total sales, and its treatment services, contributing 35%. Recent developments include the launch of a digital PET platform and expansion into Kenya, where HCG secured a major contract for oncology services. HCG’s competitive edge stems from its integrated care model and proprietary genomics platform, which differentiate it from fragmented local players. Despite a modest net income of ₹23 crore, the firm’s EBITDA marg
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,912 Cr +12.85% | ₹2,223 Cr +16.25% | ₹2,545 Cr +14.51% |
| EBITDA Margin | 17.24% | 17.42% | 18.30% |
| Net Profit | ₹48.14 Cr +64.08% | ₹44.41 Cr -7.75% | ₹13.76 Cr -69.02% |
| EPS | ₹3.46 | ₹3.19 | ₹0.97 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Healthcare Global Enterprises Share Price - Live NSE: HCG Stock Price & Chart
HealthCare Global Enterprises HCG Q2 FY27 Earnings Call Date
🔒
+ 3 more stories about Healthcare Global Enterprises Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹695 Cr, PAT ₹14 Cr, EPS ₹0.92, EBITDA margin 17.6%. Growth context: revenue YoY +13.4%, PAT YoY +189.9%, revenue QoQ +6.6%, PAT QoQ +534.6%. Street verdict: strong miss, revenue surprise -1.1%, PAT surprise -62.0%.
Management highlights new capacity addition, capex deployment, order wins, deal pipeline, and backlog build as the prima...
FY26 (last completed FY): revenue ₹2, 545 Cr, PAT ₹14 Cr, EBITDA margin 18.3%, EPS ₹0.97. Year‑on‑year: revenue YoY +14....
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for HCG
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track HCG alongside your other holdings
Unlock full HCG research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Healthcare Global Enterprises Ltd.?
NiveshIQ detects active intelligence signals for Healthcare Global Enterprises Ltd. (HCG) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Healthcare Global Enterprises Ltd.?
Healthcare Global Enterprises Ltd. operates in the Healthcare sector with a market capitalisation of ₹971,285.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.